WeissLaw

Weiss Law LLP is a national shareholder rights law firm that focuses on corporate governance, shareholder class action, and derivative litigation. The firm is highly active within the biotechnology and pharmaceutical industries, frequently launching investigations into the fairness of mergers and acquisitions involving companies in these sectors. Weiss Law represents investors who believe that corporate boards may have breached their fiduciary duties or failed to maximize shareholder value during buyouts. By filing class-action lawsuits and seeking injunctions, the firm aims to protect the interests of minority shareholders in complex corporate transactions. Their work often involves high-profile biotech deals, making them a frequent name in industry financial news.